Cleared Traditional

K831026 - INDIRECT FLUORESCENT ANTIBODY REAGENTS

K831026 is the FDA 510(k) clearance for INDIRECT FLUORESCENT ANTIBODY REAGENTS by Zeus Technologies. It is a Class 2 Microbiology device (product code LHL) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K831026 · Zeus Technologies · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1983
Decision
84d
Days
Class 2
Risk

K831026 is an FDA 510(k) clearance for the INDIRECT FLUORESCENT ANTIBODY REAGENTS. Classified as Reagents, Antibody, Legionella, Direct & Indirect Fluorescent (product code LHL), Class II - Special Controls.

Submitted by Zeus Technologies (Mchenry, US). The FDA issued a Cleared decision on June 22, 1983 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3300 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Zeus Technologies devices

Submission Details

510(k) Number K831026 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 30, 1983
Decision Date June 22, 1983
Days to Decision 84 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 102d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LHL Reagents, Antibody, Legionella, Direct & Indirect Fluorescent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LHL Reagents, Antibody, Legionella, Direct & Indirect Fluorescent

All 8
Devices cleared under the same product code (LHL) and FDA review panel - the closest regulatory comparables to K831026.
DU PONT LEGIONELLA URINARY ANTIGEN - RIA KIT
K871328 · E.I. Dupont DE Nemours & Co., Inc. · Sep 1987
LEGIONELLA PNEUMOPHILA SER. 1 ANTIGEN LATEX TEST
K864006 · Medical Diagnostic Technologies, Inc. · Apr 1987
POLYVALENT FLUORESCENT ANTIBODY REAGENTS FOR LEGIO
K854108 · Medical Diagnostic Technologies, Inc. · Nov 1985
LEGIONELLA DIRECT FLUORESCENT ANTIBODY
K812006 · Centers For Disease Control and Prevention · Sep 1981
LEGIONELLA INDIRECT FLUOR. ANTIBODY
K812007 · Centers For Disease Control and Prevention · Sep 1981